TherapeuticsMD, Inc. — Director's Dealing 2012

Mar 2, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2012-02-29

Reporting Person: Collins Cooper C. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2631579	Indirect

Footnotes

F1: Mr. Collins, as CEO, director and largest shareholder of Pernix Therapeutics Holdings, Inc., exercises voting control in part with the remaining directors of Pernix; however, he disclaims beneficial ownership of the shares.